Navigation Links
Uroplasty To Present At The JMP Securities Healthcare Conference
Date:7/5/2012

MINNEAPOLIS, July 5, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today that Susan Holman, Chief Operating Officer, and Medi Jiwani, Vice President and CFO, will present the Company's business strategy at the JMP Securities Healthcare Conference at 1:30 pm ET on Thursday, July 12, 2012 at the Peninsula New York Hotel in Manhattan.

Attendance at the conference is by invitation only.  A live audio webcast of the presentation will be broadcast via the Internet.  Those interested in listening to the webcast may access it at http://wsw.com/webcast/jmp18/upi/, or through Uroplasty's website at www.uroplasty.com. An archived replay of the presentation will be available for 90 days.

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared neuromodulation system that delivers posterior tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique® Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.

For Further Information:

Uroplasty, Inc.

David Kaysen, President and CEO, or

Medi Jiwani, Vice President, CFO, Treasurer

952.426.6140

 

EVC Group

Doug Sherk/Jenifer Kirtland (Investors), 415.568.9349

Chris Gale (Media), 646.201.5431


'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
2. Uroplasty Announces Product Development and New Clinical Trial Initiatives
3. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
4. Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
5. Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.s $1.04 Billion Civil Settlement with GlaxoSmithKline
6. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
7. Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities
8. Unigenes Oral PTH Phase 2 Proof-of-Concept Data to be Presented at Upcoming Scientific Conferences
9. Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations, Regulatory Approvals and Increasing Disease Prevalence Present Growth Opportunities
10. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
11. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... FALLS, Idaho , Feb. 21, 2017  International ... has completed a private placement with certain investors for ... stock of the Company, Series C Convertible Redeemable Preferred ... accrues dividends at an annual rate of 6% and ... The Company plans to use the proceeds for operating ...
(Date:2/21/2017)... Feb. 21, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Liver Cirrhosis Drugs Price Analysis and ... Liver Cirrhosis market. The research answers the following questions: ... and their clinical attributes? How are they positioned in the Global Liver ...
(Date:2/20/2017)... Resonance Imaging (MRI) Systems Market Outlook to 2022 ... GlobalData,s ... 2022", provides key market data on the EU5 Magnetic Resonance Imaging ... dollars, volume (in units) and average prices (USD) within market segements ... The report also provides company shares and distribution shares data for ...
Breaking Medicine Technology:
(Date:2/21/2017)... , ... February 21, 2017 , ... Ray Insurance Agencies, ... in and around Tarrant County, is embarking on a six month charity event aimed ... treatments for cancer. , Cancer is one of the deadliest diseases in America; more ...
(Date:2/21/2017)... ... February 21, 2017 , ... Each ... Black History Month (officially African American History Month ). This ... society of a diverse race of people, but also the opportunity to examine ...
(Date:2/21/2017)... ... 2017 , ... A February 6 article on Healio describes a ... that the treatments have led to significant improvements in weight loss and other health ... also noted very few problematic results relating to the treatment. Beverly Hills Physicians (BHP) ...
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... MRI screening ... to a new study from Germany published online in the journal Radiology . ... that offers better sensitivity than mammography and ultrasound. Currently, guidelines reserve breast MRI screening ...
(Date:2/20/2017)... Fla. (PRWEB) , ... February 20, 2017 , ... Scrubbing ... Cancer Center in Houston, Dr. Christopher Pezzi remembers the excitement of the surgeon training ... believe they pay us to do this? Don’t tell anyone, but I would do ...
Breaking Medicine News(10 mins):